R Bart Takkenberg

8PUBLICATIONS
59CO-AUTHORS
Cancer diagnosisDisease surveillanceHaematological tumoursNutritional epidemiologyReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 28, 2025
Correct diagnosis of patients with fibrolamellar carcinoma: A Dutch nationwide study.

Alicia Furumaya, Abisha Gumede, Víola B Weeda

|Apr 30, 2025
Rifaximin-α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization.

Diederick J van Doorn, Kirsi M A van Eekhout, Koos de Wit

|Feb 08, 2024
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial).

Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel

|Feb 10, 2023
Decompensation as initial presentation in patients with liver cirrhosis is associated with an increased risk of future decompensation and mortality.

Koos de Wit, Thijs Kuipers, Koen Van der Ploeg

|Dec 04, 2022
Rifaximin stimulates nitrogen detoxification by PXR-independent mechanisms in human small intestinal organoids.

Koos de Wit, Ulrich Beuers, Anna Mukha

|Oct 04, 2019
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.

Tim A Labeur, Sarah Berhane, Julien Edeline

Pageof 2